← Eichor
Condition: Mesothelioma Pleura Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mesothelioma Pleura

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05188859dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
Phase 1 · 1 location(s) · Erasmus Medical Center · NCT05304208A Study of Sacituzumab Govitecan in People With Mesothelioma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06477419NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a F
Phase 1/Phase 2 · 1 location(s) · University Hospital, Antwerp · NCT07121374Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and T
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06637345A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Phase N/A · 1 location(s) · University College, London · NCT05628376Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · 97 location(s) · AstraZeneca · NCT06535607Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03760575Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07443020Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07561190Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
NA · 1 location(s) · University of Chicago · NCT07126509Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
Phase 2 · 1 location(s) · The First Hospital of Jilin University · NCT06875076CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/Phase 2 · 5 location(s) · 7 Hills Pharma, LLC · NCT06362369A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previo
Phase 2 · 20 location(s) · Intergroupe Francophone de Cancerologie Thoracique · NCT06840834A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Phase N/A · 1 location(s) · Tianjin Medical University Second Hospital · NCT06031636Evaluation of Skin Tests in Biotherapy Allergies
NA · 1 location(s) · University Hospital, Angers · NCT06971848Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS
Phase N/A · 2 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06886672A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07532902A Study of MT027 in Patients with Pleural Malignant Tumors
Phase 1 · 1 location(s) · Suzhou Maximum Bio-tech Co., Ltd. · NCT06726564Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Phase 3 · 19 location(s) · Gruppo Oncologico Italiano di Ricerca Clinica · NCT04996017Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00242723Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural M
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05930665
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.